Stinson wins EMD and Merck assignment

Share this article:
Stinson Brand Innovation was awarded a global strategy assignment from EMD Biosciences and Merck Biosciences. Stinson will provide brand alignment and strategic planning services for EMD, a major supplier of premium tools for proteomics and disease pathway analysis known through its global brands Calbiochem, Novabiochem and Novagen.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Novartis apologizes for slow reporting

Novartis is apologizing to Japan after the Ministry of Health, Labor and Welfare said the company had dragged its feet reporting adverse events for two of its cancer drugs.

J&J pulls morcellator from market

The company is calling the move a withdrawal, as opposed to a recall.

Pfizer buys two Baxter vaccines

The meningitis and encephalitis medications earned a combined $300 million last year.